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Dense Deposit Disease in Korean Children: A Multicenter 
Clinicopathologic Study
The purpose of this study was to investigate the clinical, laboratory, and pathologic 
characteristics of dense deposit disease (DDD) in Korean children and to determine whether 
these characteristics differ between Korean and American children with DDD. In 2010, we 
sent a structured protocol about DDD to pediatric nephrologists throughout Korea. The 
data collected were compared with previously published data on 14 American children 
with DDD. Korean children had lower 24-hr urine protein excretion and higher serum 
albumin levels than American children. The light microscopic findings revealed that a 
higher percentage of Korean children had membranoproliferative glomerulonephritis 
patterns (Korean, 77.8%; American, 28.6%, P = 0.036), whereas a higher percentage of 
American children had crescents (Korean, 0%; American, 78.6%, P < 0.001). The findings 
from the electron microscopy revealed that Korean children were more likely to have 
segmental electron dense deposits in the lamina densa of the glomerular basement 
membrane (Korean, 100%; American, 28.6%, P = 0.002); mesangial deposit was more 
frequent in American children (Korean, 66.7%; American, 100%, P = 0.047). The 
histological findings revealed that Korean children with DDD were more likely to show 
membranoproliferative glomerulonephritis patterns than American children. The degree of 
proteinuria and hypoalbuminemia was milder in Korean children than American children. 
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INTRODUCTION
Dense deposit disease (DDD) is a rare glomerulonephritis that 
typically affects children between the ages of 5 and 15 yr old (1). 
The prevalence of DDD is estimated at only two to three people 
per million, but about 50% of these patients proceed to end-stage 
renal failure within 10 yr of diagnosis (2, 3). Although the follow-
ing findings are nonspecific, DDD is clinically characterized by 
hematuria, proteinuria, acute nephritic syndrome, or nephrotic 
syndrome. Spontaneous remission is extremely rare (1).   
 DDD has previously been referred to as membranoprolifera-
tive glomerulonephritis (MPGN) type II, but it differs markedly 
from other MPGN types in pathogenesis. When Galle (4) first 
described DDD in 1962, he reported an electron dense transfor-
mation of the glomerular basement membranes (GBM). How-
ever, under electron microscopy, the morphologic hallmark of 
DDD is the transformation of the lamina densa of the GBM, 
which shows an intense deposition of C3 in a ribbon-like pat-
tern along the GBM, tubular basement membrane, and the wall 
of Bowman’s capsule. 
 A few recent studies have examined the clinicopathologic 
characteristics of patients with DDD (5, 6). For example, one 
study compared the clinicopathologic features of DDD in chil-
dren and adults (5). However, it is unknown whether the clini-
copathologic course and prognosis differs between Asian and 
Western children with DDD. Thus, we investigated all DDD cases 
previously reported and newly recruited the Korean pediatric 
population and compared the outcomes and clinicopathologic 
features with those of American children. The aim of this study 
was to investigate the clinical, laboratory, and pathologic char-
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acteristics of DDD in Korean children, and to determine whether 
these characteristics differed from those of American children 
with DDD.
MATERIALS AND METHODS
Study design and patients
In 2010, we sent a structured protocol for this study to pediatric 
nephrologists working at university hospitals in Korea. Nine pa-
tients with DDD were recruited from six hospitals; the study 
population included 6 males and 3 females (mean age, 9.0 yr; 
range, 4-13.1 yr). We investigated the clinicopathologic features 
of DDD from the protocols. The following clinical data were doc-
umented: age and gender of patients, peripheral edema, oligu-
ria, hypertension, 24-hr urine protein, nephrotic syndrome, al-
bumin, hematuria, red blood cell casts, serum creatinine at re-
nal biopsy, C3, C4, preceding infection, duration of follow-up, 
treatment, and outcome. These data were compared with pre-
viously published data on 14 American children with DDD (5). 
Table 1 summarizes the patient demographics.
 All participants were native Koreans without any significant 
previous medical conditions. DDD was diagnosed by the pa-
thologists at each hospital, and the histological photographs 
and clinical data for each patient were obtained from their pe-
diatric nephrologists.
Histological data
The diagnosis of DDD was based on the ultrastructural finding 
of a transformation of the glomerular basement membranes by 
ribbon-like, highly electron-dense material and a high degree 
of immunofluorescence staining for C3. Initial renal biopsy slides 
and photographs were reviewed by a pathologist at Yonsei Uni-
versity Severance Hospital to assess the pathological features of 
DDD using light microscopy (LM), immunofluorescence (IF), 
and electron microscopy (EM). A diagnosis of DDD was con-
firmed for all nine patients. 
 When using LM, DDD exhibited 4 different histologic pat-
terns; mesangial proliferative glomerulonephritis (GN), endo-
capillary proliferative GN, MPGN, and crescentic GN. LM find-
ings included the number of glomeruli and crescents, the per-
centage of globally and segmentally sclerotic glomeruli, necro-
sis, endocapillary hypercellularity, intracapillary neutrophil in-
filtration, interstitial inflammation, tubular atrophy, and inter-
stitial fibrosis. Staining intensity was graded 0 (negative) to 3+ 
(severe) on a semiquantitative scale for IgG, IgA, IgM, C3, and 
C1q. Ultrastructural evaluation was performed with a transmis-
sion electron microscope. 
Definitions
Nephrotic syndrome was defined as the presence of nephrotic 
range proteinuria, hypoalbuminemia, hyperlipidemia, and pe-
ripheral edema. Nephrotic range proteinuria was defined as a 
24-hr urine protein > 40 mg/m2/hr, or a spot urine protein-to-
creatinine ratio ≥ 2. Hypoalbuminemia was defined as a serum 
albumin level ≤ 2.5 g/dL. Hematuria was defined as ≥ 5 red 
blood cells per high power field on microscopic examination of 
the urinary sediment or positive blood identification by dipstick. 
The terms “focal” and “diffuse” refer to disease infiltration of 
≤ 50% or > 50% of glomeruli, respectively.
 The pathological features of MPGN were classified into three 
subtypes. Type I classical MPGN is the most common variant 
characterized by subendothelial immune deposits in the capil-
lary wall and is associated with an activation of the classical com-
plement pathway (7). In type II MPGN (DDD), intramembra-
nous electron dense deposits are seen within the glomerular, 
tubular and Bowman’s capsular basement membrane, which is 
associated with C3 nephritic factor and persistent activation of 
the alternative complement pathway (7). Type III MPGN is con-
sidered a morphologic variant of type I characterized by subep-
ithelial as well as subendothelial deposits. (7)
Statistical analysis
Statistical analyses were performed with SPSS for Windows ver-
sion 18.0 (SPSS, Chicago, IL, USA). Descriptive statistics are ex-
pressed as mean ± standard deviation. As appropriate, addi-
tional analyses were performed with nonparametric statistical 
methods, including Mann-Whitney test, Fisher’s exact test and 
the Wilcoxon rank-sum test. P < 0.05 was considered statistical-
ly significant. 
Ethics statement
This study was approved by the institutional review board of 
Yonsei University Severance Hospital (IRB approval number: 
4-2011-0106). The board exempted written informed consent 
from all study participants.
 
RESULTS
The subject population included nine children: two children 
Table 1. Demographics of nine Korean patients with dense deposit disease
Parameters     Number (%)
Female:male    3:6
Age (yr)
   0 to 5
   6 to 10
   11 to 15
  
     2 (22.2)
     5 (55.5)
     2 (22.2)
Body surface area (m2)
   0 to 0.5
   0.6 to 1.0
  > 1.0
 
0 (0)
     3 (33.3)
     6 (66.6)
Body mass index (kg/m2)
   10 to 14
   15 to 19
   20 to 24
 
     5 (55.5)
     2 (22.2)
     2 (22.2)
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≤ 5 yr of age and seven children > 6 yr of age (Table 1). The ratio 
of males to females was 2.0, and the mean age was 9.0 yr (range 
4-13.1 yr). No children were overweight or obese, and none had 
a history of comorbid conditions, such as hypertension. The 
development of renal symptoms was preceded by an acute in-
fection in 33.3% of patients (Table 2).
 Although all patients had proteinuria at presentation, only 
three children (33.3%) developed nephrotic range proteinuria. 
The mean 24-hr urine protein was 1.25 g. Decreased C3 levels 
were present in eight patients (88.9%), whereas C4 was depressed 
in only two patients (22.2%) (Table 3). Gross and microscopic 
hematuria were present in 33.3% and 100% of patients, respec-
tively. The mean serum albumin level was within normal limits. 
At presentation, renal insufficiency was documented in only 
one patient (11.1%), and the mean serum creatinine at biopsy 
was 0.65 mg/dL. There were no differences between Korean 
and American children in age, gender, hematuria, generalized 
edema, and serum creatinine levels at presentation. However, 
Korean children had lower mean 24-hr urine protein excretion 
(Korean, 1.25 g; American, 4.0 g, P < 0.001) and higher mean 
serum albumin levels (Korean, 3.7 g/dL; American, 2.7 g/dL, 
P = 0.021) than American children (Table 3).
 The light microscopic findings revealed that the most com-
mon histological pattern for DDD was MPGN, found in 77.8% 
of Korean patients; the next most common pattern was endo-
capillary proliferative GN with or without exudative features 
(22.2%) (Table 4). One patient had MPGN that resulted from 
mesangial proliferative GN. One other patient had MPGN that 
resulted from endocapillary proliferative GN. The MPGN pat-
tern was associated with more endocapillary hypercellularity 
and intracapillary neutrophil infiltration than other patterns. No 
crescentic GN was observed (Fig. 1A, B). A significantly higher 
percentage of Korean patients had MPGN patterns (Korean, 
77.8%; American, 28.6%, P = 0.036), whereas a significantly high-
er percentage of American children had crescents (Korean, 0%; 
American, 78.6%, P < 0.001) (Table 5). Segmentally sclerotic 
glomeruli were observed in 13.4% of Korean patients; however, 
none was observed in the American children.
 Using immunofluorescence (Fig. 1C), we detected intense 
C3 staining along the glomerular capillary wall of 87.5% of Ko-
rean patients (mean intensity 1.7+). C1q and IgA positivity were 
absent. There were no differences in C3, C1q, IgG, IgM, and IgA 
depositions between Korean and American children (Table 6). 
 Electron microscopy confirmed the distinguishing character-
Table 2. Clinical characteristics at presentation and follow-up in Korean patients
No.
Preceding 
infection
Peripheral 
edema
Oliguria
Hyper- 
tension
24 hr  
urine  
protein (mg)
Gross  
hema- 
turia
Serum  
albumin  
(g/dL)
Serum  
creatinine 
at biopsy 
(mg/dL)
C3  
(mg/dL)
C4  
(mg/dL)
Treatment Outcome
Duration of 
follow-up 
(months)
1 - - - - 49 - 5.0 0.6 15    15.9 ACEi PRD*   14
2 - - - - 5,000 - 2.7 0.5 49.6    16.8 Combined† PRD   54
3 - + + - 2,625 + 2.3 1.17 125    71.7 Combined CR‡   87
4 - - - - 583 - 3.6 0.59 60    25.4 Combined PRD   54
5 + - - - 350 + 3.5 0.4 8 33 ACEi PRD 204
6 - - - - 197 - 4.1 0.7 17      8.3 ACEi PRD     8
7 + - - - 78 - 3.9 0.9 12.5    21.3 Combined CR 126
8 + + - - 2,200 + 3.4 0.6 26 48 IS CR 156
9 - - - - 120 - 4.2 0.46 16.1      7.7 ACEi PRD     1
*Persistent renal dysfunction; †Immunosuppressive agents/renin angiotensin system blockade; ‡Complete response.
Table 3. Clinical characteristics at presentation of DDD
Characteristics 
American 
children (5)  
(n = 14) 
Korean   
children  
(n = 9) 
P  value 
Peripheral edema 6 (42.8) 2 (22.2) 0.400 
Mean 24-hr urine protein  
   Proteinuria < 1 g/24 hr 
   Proteinuria 1 to 3 g/24 hr 
   Proteinuria > 3 g/24 hr 
4.0 
2/13 (15.4) 
4/13 (30.8) 
7/13 (53.8) 
1.25 
6 (66.7) 
2 (22.2) 
1 (11.1) 
0.001
0.026 
0.999 
0.074 
Full nephrotic syndrome 4/13 (30.8) 2 (22.2) 0.999 
Mean serum albumin (g/dL) 2.7 3.65 0.021
Hematuria (microscopic or macroscopic) 
   Macroscopic hematuria 
   Red blood cell casts 
13/13 (100) 
3/13 (23.1) 
6/13 (46.2) 
9 (100) 
3 (33.3) 
1 (11.1) 
0.999 
0.655 
0.165 
Mean serum creatinine at biopsy (mg/dL) 
   Renal insufficiency at presentation 
0.8 
5 (35.7) 
0.65 
1 (11.1) 
0.340 
Low C3 13/13 (100) 8 (88.9) 0.409 
Low C4 0/13 (0) 2 (22.2) 0.156 
Preceding infection 8 (57.1)* 3 (33.3)† 0.400 
Numbers in parentheses are percentages. *Pneumonia in four patients, upper respi-
ratory tract infection in three patients, and bronchitis in one patient; †Upper respiratory 
tract infection in three patients.
Table 4. Histological pattern by light microscopy
Pattern of histology
American  
children (5)  
(n = 14) 
    Korean  
    children  
    (n = 9) 
P  value 
Mesangial proliferative GN 4 (28.6) 0 (0) 0.254 
Endocapillary proliferative GN with 
   or without exudative features 
3 (21.4)      2 (22.2) 0.999 
Membranoproliferative GN 4 (28.6)      7 (77.8) 0.036 
Crescentic GN* 3 (21.4) 0 (0) 0.273 
Numbers in parentheses are percentages. *Defined by the presence of crescents affect-
ing ≥ 50% of glomeruli.
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istic of DDD: electron-dense deposits that had irregularly thick-
ened and transformed the lamina densa (Fig. 1D). In the GBM 
of all patients, the intramembranous deposits were segmentally 
interrupted. The deposits also involved the mesangium (66.7% 
Table 5. Light microscopic findings
Pathologic findings American children (5) (n = 14) Korean children (n = 9)  P value 
Mean number of glomeruli  24.4  37.0 0.207 
Percent of globally sclerotic glomeruli    2.9   8.6 0.304 
Percent of segmentally sclerotic glomeruli 0  13.4 0.068 
Percent of cases with crescents* 
   Focal 
   Diffuse 
11 (78.6) 
8 
3 
     0 (0) 
0 
0 
< 0.001 
0.007 
0.253 
Number of cases with necrosis 1 (7.1)      0 (0) 0.999 
Number of cases with endocapillary hypercellularity* 
   Focal 
   Diffuse 
10 (71.4) 
6 
4 
         6 (66.7) 
5 
1 
0.999 
0.680 
0.611 
Number of cases with intracapillary neutrophil infiltration* 
   Focal 
   Diffuse 
  8 (57.1) 
6 
2 
         5 (55.6) 
3 
2 
0.999 
0.691 
0.999 
Interstitial inflammation: none/focal/diffuse† 5/7/2 8/1/0 0.041 
Tubular atrophy and interstitial fibrosis (none/mild/moderate/severe)‡ 8/5/1/0 6/3/0/0 0.999 
Arteriosclerosis and arteriolar hyalinosis (none/mild/moderate/severe) 13/1/0/0 8/1/0/0 0.999
Numbers in parentheses are percentages. *Focal, ≤ 50% of glomeruli; diffuse, > 50% of glomeruli; †Focal, ≤ 50% of cortical surface area; diffuse, > 50%; ‡Mild: 0 to 25% 
of cortical surface area; moderate: 26 to 50%; severe: > 50%.
Fig. 1. Light, immunofluorescence, and electron microscopy findings in a Korean case of dense deposit disease. (A) Cellular proliferation leads to lobule formation in the glom-
erulus (H&E, × 200). (B) The glomerular capillary wall is thickened focally, but the doubling or splitting observed in type I MPGN is not observed (arrow) (Periodic acid methena-
mine silver, × 400). (C) C3 immunofluorescence deposits along the glomerular capillary wall have a linear rather than a granular pattern (× 200). (D) Intramembranous electron 
dense deposits with a ribbon or sausage shape (arrows) are visible under the electron microscope (× 4,000).
A B
C D
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of patients), focal subepithelium (22.2% of patients), subendo-
thelium (22.2% of patients), and tubular basement membranes 
(11.1% of patients) (Table 7). Korean children were more likely 
to have segmental electron dense deposits in the lamina densa 
of the GBM (Korean, 100%; American, 28.6%, P = 0.002), but 
American children were more likely to have mesangial deposits 
(Korean, 66.7%; American, 100%, P = 0.047). 
 The mean duration of follow-up for Korean patients was 78.2 
months (range, 1 to 204 months). Treatment for DDD involved 
renin angiotensin system (RAS) blockade (angiotensin convert-
ing enzyme inhibitor and/or angiotensin II receptor blocker) in 
four patients; immunosuppression (IS) in one patient; and com-
bined RAS blockade/IS in four patients (Table 8). Steroids were 
used for IS in all five patients. Among the five patients who re-
ceived IS therapy, two had nephrotic syndrome in the follow-
up period (40%), four had decreased C3 levels (80%), and one 
had renal insufficiency (20%) on admission. At the final follow-
up, no patients had progressed to end-stage renal disease, but 
66.7% experienced persistent renal dysfunction, such as micro-
scopic hematuria and proteinuria. The clinical outcomes did 
not differ significantly between Korean and American children.
DISCUSSION
The purpose of this multicenter study was to identify the clini-
copathologic characteristics and outcomes of Korean children 
with DDD and to compare these characteristics and outcomes 
with those of American children. We found that DDD was ex-
tremely rare in Korea, with only a small number of DDD cases 
published during the past 3 decades (8-13). In contrast to the 
reports from America (5), most patients in our study had a good 
prognosis, including one case that completely resolved. Unfor-
tunately, the rarity of DDD has resulted in a limited understand-
ing of the clinicopathologic findings and natural course of the 
disease in the Korean population. Thus, our study focused on 
the cliniopathologic characteristics of DDD and if these charac-
teristics differed from patients with DDD in America.  
 Although DDD usually affects patients between the ages of 
5 and 15 yr (14), this age range can vary considerably, from 1 to 
64 yr (15, 16). In a study by Nasr et al. (5), all 14 children in the 
cohort were over 5 yr of age. In contrast, 2 children (22.2%) in 
our study were less than 5 yr at the onset of DDD, and DDD was 
twice as common in male patients as females. Thus, our data 
suggest that DDD in Asian children may occur at an earlier age 
than in American children and that it may occur more frequent-
ly in males. 
 Patients with DDD exhibit various clinical manifestations, 
such as peripheral edema, nephrotic syndrome, hypertension, 
gross hematuria, and persistent hypocomplementemia. These 
findings are not specific to DDD. However, recent efforts have 
attempted to find an association between clinical predictive fac-
tors and poor outcome in DDD (5, 6, 14). Nasr et al. (5) found 
that older age and higher serum creatinine at biopsy to predict a 
poor prognosis in DDD patients, while Appel et al. found that 
glomerular crescents or tubular atrophy at biopsy to predict poor 
outcomes (14). Another recent study found that a greater per-
centage of females than males were on dialysis in the ‘younger 
Table 6. Immunofluorescence findings
Target molecules
No. (%) of positive patients
P  value American children (5) 
(n = 14) 
Korean children  
(n = 8) 
C3 14 (100) 
(2.6+) 
7/8 (87.5)
(1.7+)
0.364
C1q    3 (21.4) 
(1.8+) 
0/8 (0)
(0)
0.273
IgG    5 (35.7) 
(1.3+) 
1/8 (12.5)
(0.5+)
0.351
IgM    8 (57.1) 
(0.9+) 
2/8 (25)
(0.8+)
0.204
IgA  1 (7.1)
(1+) 
0/8 (0)
(0)
1.000
Data indicate the number (percentage) of positive patients and the mean intensity of 
staining when positive (scale: 0.5, 1 to 3+).
Table 7. Electron microscopic findings
Location of highly electron-dense 
   deposits 
American  
children (5)  
(n = 14) 
Korean  
children  
(n = 9) 
P  value 
Lamina densa of GBM* 
   Segmental† 
   Global†
14 (100) 
4 (28.6)
10 (71.4)
9 (100) 
9 (100)
0 (0)
0.999
0.002
0.127
Mesangial 
   Segmental† 
   Global† 
14 (100) 
7 (50)
7 (50)
6 (66.7) 
6 (66.7)
0 (0)
0.047
0.686
0.023
Subepithelial hump-shaped deposits 2 (14.3) 2 (22.2) 0.999 
Subendothelial 5 (35.7) 2 (22.2) 0.657 
Bowman’s capsule 6 (42.9) 0 (0) 0.048 
Tubular basement membranes 6 (42.9) 1 (11.1) 0.176 
Numbers in parentheses are percentages. *GBM, glomerular basement membranes; 
†Segmental, involving < 50% of the glomerular loops; global, involving ≥ 50% of glo-
merular loops.
Table 8. Clinical follow-up
Parameters
American  
Children (5)  
(n = 14)
Korean  
Children  
(n = 9)  
P  value 
Duration of follow-up: mean (range) 
   in months 
79.4  
(2 to 288) 
78.2  
(1 to 204) 
0.391 
Treatment 
   RAS* blockade alone 
   IS* alone (steroid or 2nd agents) 
   Combined IS/RAS blockade 
 
  2 (15.4) 
  3 (23.1) 
  8 (61.5) 
 
      4 (44.4) 
      1 (11.1) 
      4 (44.4) 
0.432 
Outcome† 
   Complete response 
   Persistent renal dysfunction 
   ESRD 
 
  6 (46.1) 
  6 (46.1) 
1 (7.7) 
 
      3 (33.3) 
      6 (66.7) 
      0 (0) 
0.799 
Numbers in parentheses are percentages, unless otherwise indicated. *RAS, renin 
angiotensin system; IS, immunosuppressive agents (steroids with or without a second 
agent); †Overall comparison, complete response/persistent renal dysfunction/ESRD in 
American children versus Korean children.
Park SJ, et al. • Dense Deposit Disease in Korean Children
1220  http://jkms.org http://dx.doi.org/10.3346/jkms.2012.27.10.1215
population’ (50% vs 27%, respectively, P = 0.036), and renal fail-
ure was more common among patients who had DDD for at 
least 10 yr since diagnosis (53% vs 32%, P = 0.044) (6). Previous 
reports suggest that renal function slowly deteriorates for rough-
ly 50% of patients with DDD, and that patients progress to end-
stage renal disease and require dialysis within 10 yr of onset (6, 
17, 18). In contrast, all patients with DDD in our study had a 
good clinical prognosis, and one patient had complete resolu-
tion of DDD after a high dose of prednisolone. Although the 
cause of this difference is unknown, we suggest that it may be 
due to the younger age of our patients, their milder proteinuria 
and hypoalbuminemia, the absence of glomerular crescents, 
relatively well-preserved renal function, normal blood pressure, 
and lower 24-hr protein excretion. In addition, more segmental 
electron dense deposits in the lamina densa of the GBM may 
have favored the resolution of DDD instead of diffuse dense de-
posits in the GBM and mesangium. Improvements to the uri-
nary screening policy of schools in Korea may also encourage 
the earlier detection and management of DDD in children. How-
ever, further studies are needed in a larger population to inves-
tigate these possibilities.
 The distinct pathologic features of DDD are the dense intra-
membranous deposits and transformation of the GBM observed 
with electron microscopy. These changes are distributed in a 
segmental, discontinuous, interrupted, or continuous and dif-
fuse pattern in the lamina densa of the GBM (19-21). In our 
study, the histological patterns of DDD did not differ between 
Korean and American children. However, the light microscopic 
findings revealed that the percentage of patients with crescents 
and interstitial inflammation was higher in American than Ko-
rean children. The location of highly electron-dense deposits 
was more segmental in Korean than American children. Elec-
tron-dense deposits in Bowman’s capsule were more frequent 
in American children. In our study, two patients had DDD that 
resulted from either mesangial proliferative GN or endocapil-
lary proliferative GN. Subepithelial and subendothelial electron 
dense deposits were also observed, as well as intramembranous 
deposits. These deposits were associated with mesangial prolif-
eration and interposition. Although MPGN patterns were more 
prevalent in Korean patients than American children, diverse 
features of mesangial proliferative change, membranoprolifera-
tive change, and minor glomerular alterations were also present.
 The clinical and morphological diversity of DDD makes it dif-
ficult for clinicians to differentiate DDD from other glomerulo-
nephritic diseases. In children, hematuria and a decrease in C3 
levels may lead to a diagnosis of poststreptococcal GN and lupus 
nephritis. Presentation with acute nephritic syndrome and C3 
deposits along the capillary loops can be observed both in post-
stereptococcal GN and in DDD without membranoproliferation. 
Therefore, EM examination through renal biopsy is necessary 
to distinguish between them. Intramemtranous electron dense 
deposits may be observed in the Anders and Strife variant of 
MPGN type III, but breaks and lamellations in the intervening 
lamina densa are usually associated with electron dense depos-
its (22). Persistent C3 deposits, regardless of morphologic trans-
formation and areas of continuous intramembranous deposits 
along the lamina densa, can also support the diagnosis of DDD.
 Many different treatment options use renin angiotensin sys-
tem blockade, such as angiotensin converting enzyme inhibi-
tors and angiotensin receptor blockers, immunosuppression 
with corticosteroids, cytotoxic drugs, anticoagulants, and anti-
platelet agents. The knowledge and understanding of the patho-
physiology of DDD has grown (14, 17, 23). For example, more 
specific and effective treatment options have become available, 
such as plasmapheresis with or without plasma exchange to re-
place factor H deficiency (24-26), intravenous infusion of immu-
noglobulin to interrupt the C3 convertase-induced rapid am-
plification feedback loop (27, 28), and eculizumab to inhibit ac-
tivation of the terminal pathway of the complement against C5 
(29, 30). Similar to other studies (5, 6), we found that renin an-
giotensin system blockade and prednisolone were the most fre-
quently prescribed medications for DDD - both had good ther-
apeutic responses. 
 Our study has some limitations. We were only able to enroll a 
small number of patients due to the extreme rarity of DDD. We 
also did not repeat biopsies in the study patients, and the follow-
up duration was relatively short. In addition, this was a retro-
spective study; therefore, the accuracy of our data could have 
been affected by the memory of the informants. A prospective 
cohort study with a larger number of DDD patients is needed to 
establish the clinicophathologic course, outcome, and evidence-
based practice guidelines for better treatment of DDD, includ-
ing consideration of any ethnic differences. 
 In summary, our histological findings revealed that Korean 
children with DDD were more likely to show membranoprolif-
erative glomerulonephritis patterns than American children. 
In addition, proteinuria and hypoalbuminemia were milder in 
Korean than American children, although the clinical outcomes 
did not differ between groups. These findings should be con-
firmed through future studies involving a greater number of 
patients with DDD. Due to the rarity of DDD, such studies will 
require a collaborative effort between multiple research facili-
ties. To this end, we invite other researchers to contact us about 
future participation in an international collaborative research 
survey of patients with DDD. 
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